BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17884735)

  • 21. Analyses of cumulative incidence functions via non-parametric multiple imputation.
    Ruan PK; Gray RJ
    Stat Med; 2008 Nov; 27(27):5709-24. PubMed ID: 18712779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of effect sizes reported at multiple time points: a multivariate approach.
    Trikalinos TA; Olkin I
    Clin Trials; 2012 Oct; 9(5):610-20. PubMed ID: 22872546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death.
    Shuster JJ; Jones LS; Salmon DA
    Stat Med; 2007 Oct; 26(24):4375-85. PubMed ID: 17768699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses.
    Brok J; Thorlund K; Wetterslev J; Gluud C
    Int J Epidemiol; 2009 Feb; 38(1):287-98. PubMed ID: 18824466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining multiple outcome measures in a meta-analysis: an application.
    Arends LR; Vokó Z; Stijnen T
    Stat Med; 2003 Apr; 22(8):1335-53. PubMed ID: 12687658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis methodology for combining treatment effects from Cox proportional hazard models with different covariate adjustments.
    Yuan X; Anderson SJ
    Biom J; 2010 Aug; 52(4):519-37. PubMed ID: 20661952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
    Thorlund K; Devereaux PJ; Wetterslev J; Guyatt G; Ioannidis JP; Thabane L; Gluud LL; Als-Nielsen B; Gluud C
    Int J Epidemiol; 2009 Feb; 38(1):276-86. PubMed ID: 18824467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of repeated measures study designs.
    Peters JL; Mengersen KL
    J Eval Clin Pract; 2008 Oct; 14(5):941-50. PubMed ID: 19018929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bivariate random effects meta-analysis of ROC curves.
    Arends LR; Hamza TH; van Houwelingen JC; Heijenbrok-Kal MH; Hunink MG; Stijnen T
    Med Decis Making; 2008; 28(5):621-38. PubMed ID: 18591542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses.
    Koopman L; van der Heijden GJ; Hoes AW; Grobbee DE; Rovers MM
    Int J Technol Assess Health Care; 2008; 24(3):358-61. PubMed ID: 18601805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of meta-analyses and of large randomized trials in the study of cancer treatments.
    Pignon JP; Auperin A; Borget I; Hill C
    Lung Cancer; 2009 Jul; 65(1):9-12. PubMed ID: 19059671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses.
    Brok J; Thorlund K; Gluud C; Wetterslev J
    J Clin Epidemiol; 2008 Aug; 61(8):763-9. PubMed ID: 18411040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model selection for multi-component frailty models.
    Ha ID; Lee Y; MacKenzie G
    Stat Med; 2007 Nov; 26(26):4790-807. PubMed ID: 17476647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology.
    Nelson CL; Sun JL; Tsiatis AA; Mark DB
    Stat Med; 2008 Nov; 27(26):5525-55. PubMed ID: 18613251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On robustness of marginal regression coefficient estimates and hazard functions in multivariate survival analysis of family data when the frailty distribution is mis-specified.
    Hsu L; Gorfine M; Malone K
    Stat Med; 2007 Nov; 26(25):4657-78. PubMed ID: 17348081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trials of amifostine and radiotherapy: effect on survival?
    Bourhis J; Thephamongkhol K; Pignon JP
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):62-6. PubMed ID: 15726526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of diagnostic test studies using individual patient data and aggregate data.
    Riley RD; Dodd SR; Craig JV; Thompson JR; Williamson PR
    Stat Med; 2008 Dec; 27(29):6111-36. PubMed ID: 18816508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of factorial survival experiments.
    Slud EV
    Biometrics; 1994 Mar; 50(1):25-38. PubMed ID: 8086609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of methods of handling missing data in individual patient data meta-analyses: an empirical example on antibiotics in children with acute otitis media.
    Koopman L; van der Heijden GJ; Grobbee DE; Rovers MM
    Am J Epidemiol; 2008 Mar; 167(5):540-5. PubMed ID: 18184640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.